McKesson/Celesio Deal Targets Generics Purchasing Synergies
This article was originally published in The Pink Sheet Daily
Executive Summary
McKesson believes its acquisition of European drug wholesaler Celesio will result in $275 million to $325 million in synergies four years out, and much of the savings will be achieved through generic drug purchasing.
You may also be interested in...
Walgreens Grows Internationally With Alliance Boots Stake
Walgreens is acquiring 45% of the U.K.-based international retailer and wholesaler Alliance Boots, which runs pharmacies in 11 countries, with an option to acquire the entire firm in three years.
Business News, In Brief
Companies talk drug launches and pipelines during first quarter earnings calls in May; with some having more success than others.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.